Clinical Report: Highlights From Atlantic Coast Retina Club and Macula 2026
Overview
The Atlantic Coast Retina Club and Macula 2026 conference showcased emerging therapies and surgical techniques in retinal care. Key presentations included novel treatment approaches for ocular oncology and inherited retinal diseases, emphasizing the importance of comprehensive patient evaluation.
Background
The Atlantic Coast Retina Club and Macula conference serves as a pivotal educational forum for retinal specialists, marking its 50th anniversary in 2026. This meeting provides a platform for sharing innovative case studies and discussing advancements in the management of retinal diseases, which are crucial for improving patient outcomes. Understanding the latest therapeutic strategies is essential for clinicians to enhance their practice and patient care.
Data Highlights
No numerical data was provided in the source material.
Key Findings
- Systemic cell-free DNA levels dropped significantly following enucleation in a retinoblastoma case, supporting intra-arterial chemotherapy.
- Intra-arterial chemotherapy was effective in treating metastatic cutaneous melanoma in the subretinal space.
- A case of choroidal thickening in a diabetic patient led to the discontinuation of dulaglutide, highlighting the need for awareness of GLP-1 receptor agonists' ocular side effects.
- Inflammatory mimickers of retinal diseases were discussed, emphasizing the importance of multimodal imaging for accurate diagnosis.
- Trauma-induced lipofuscin accumulation may serve as a biomarker of retinal vulnerability in patients with inherited retinal diseases.
- Continued genetic evaluation is recommended when clinical suspicion persists in complex cases.
Clinical Implications
Clinicians should consider the implications of systemic treatments on ocular conditions and remain vigilant for potential side effects. The findings underscore the importance of thorough patient evaluations, including genetic assessments, to inform treatment decisions and improve management strategies for retinal diseases.
Conclusion
The Atlantic Coast Retina Club and Macula 2026 conference highlighted significant advancements in retinal care, emphasizing the need for ongoing education and adaptation of clinical practices based on emerging evidence.
Related Resources & Content
- Retinal Physician, Macula 2009: Highlights From the Conference, 2009 -- A host of retinal physicians offer the latest tips on treatment and trial results
- Optometric Management, American Academy of Optometry Announces Registration Open for 2026 Retina Summit, 2026 -- Registration has opened for the 2026 Retina Summit
- Age-Related Macular Degeneration Preferred Practice Pattern® - Oregon Health & Science University, 2026 -- Current guidance and pivotal anti-VEGF data
- Pegcetacoplan Treatment for Geographic Atrophy in Age-Related Macular Degeneration Over 36 Months: Data From OAKS, DERBY, and GALE, 2026 -- Long-term efficacy signals for pegcetacoplan
- retinal physician — A New Year
- optometric management — Retina in Modern Optometry: Takeaways from the American Academy of Optometry's 2026 Retina Summit
- Retina in Modern Optometry: Takeaways from the American Academy of Optometry's 2026 Retina Summit
- A New Year
- Age-Related Macular Degeneration Preferred Practice Pattern® - Oregon Health & Science University
- Pegcetacoplan Treatment for Geographic Atrophy in Age-Related Macular Degeneration Over 36 Months: Data From OAKS, DERBY, and GALE - PubMed
- 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026 - PubMed
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
